PreveCeutical Medical Inc. 18H.F Stock
PreveCeutical Medical Inc. Price Chart
PreveCeutical Medical Inc. 18H.F Financial and Trading Overview
| PreveCeutical Medical Inc. stock price | 0.02 EUR |
| Previous Close | 0.02 EUR |
| Open | 0.02 EUR |
| Bid | 0.02 EUR x 0 |
| Ask | 0.03 EUR x 0 |
| Day's Range | 0.02 - 0.02 EUR |
| 52 Week Range | 0.0048 - 0.03 EUR |
| Volume | 2.5K EUR |
| Avg. Volume | 4.39K EUR |
| Market Cap | 9.64M EUR |
| Beta (5Y Monthly) | 0.992303 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
18H.F Valuation Measures
| Enterprise Value | 13.09M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -11.315 |
Trading Information
PreveCeutical Medical Inc. Stock Price History
| Beta (5Y Monthly) | 0.992303 |
| 52-Week Change | 275.00% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.03 EUR |
| 52 Week Low | 0.0048 EUR |
| 50-Day Moving Average | 0.02 EUR |
| 200-Day Moving Average | 0.02 EUR |
18H.F Share Statistics
| Avg. Volume (3 month) | 4.39K EUR |
| Avg. Daily Volume (10-Days) | 250 EUR |
| Shares Outstanding | 535.3M |
| Float | 404.7M |
| Short Ratio | N/A |
| % Held by Insiders | 24.08% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 5:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -455.59% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -1157247 EUR |
| Net Income Avi to Common (ttm) | -1261495 EUR |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.08K EUR |
| Total Cash Per Share (mrq) | 0 EUR |
| Total Debt (mrq) | 3.47M EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.008 |
| Book Value Per Share (mrq) | -0.009 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -75099 EUR |
| Levered Free Cash Flow (ttm) | -157629 EUR |
Profile of PreveCeutical Medical Inc.
| Country | Germany |
| State | BC |
| City | Vancouver |
| Address | 885 Cambie Street |
| ZIP | V6B 0R6 |
| Phone | 604 416 7777 |
| Website | https://www.preveceutical.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; BSV Peptide Program that targets cancer progression; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.
Q&A For PreveCeutical Medical Inc. Stock
What is a current 18H.F stock price?
PreveCeutical Medical Inc. 18H.F stock price today per share is 0.02 EUR.
How to purchase PreveCeutical Medical Inc. stock?
You can buy 18H.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PreveCeutical Medical Inc.?
The stock symbol or ticker of PreveCeutical Medical Inc. is 18H.F.
Which industry does the PreveCeutical Medical Inc. company belong to?
The PreveCeutical Medical Inc. industry is Biotechnology.
How many shares does PreveCeutical Medical Inc. have in circulation?
The max supply of PreveCeutical Medical Inc. shares is 607.65M.
What is PreveCeutical Medical Inc. Price to Earnings Ratio (PE Ratio)?
PreveCeutical Medical Inc. PE Ratio is now.
What was PreveCeutical Medical Inc. earnings per share over the trailing 12 months (TTM)?
PreveCeutical Medical Inc. EPS is 0 EUR over the trailing 12 months.
Which sector does the PreveCeutical Medical Inc. company belong to?
The PreveCeutical Medical Inc. sector is Healthcare.